Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

SELL
$14.33 - $18.37 $11,879 - $15,228
-829 Reduced 1.25%
65,307 $0
Q3 2022

Oct 26, 2022

BUY
$13.07 - $18.22 $864,397 - $1.2 Million
66,136 New
66,136 $1.04 Million
Q2 2022

Jul 25, 2022

SELL
$10.16 - $17.08 $78,496 - $131,960
-7,726 Closed
0 $0
Q1 2022

May 02, 2022

SELL
$9.74 - $17.92 $8,113 - $14,927
-833 Reduced 9.73%
7,726 $133,000
Q4 2021

Jan 28, 2022

BUY
$12.27 - $18.49 $105,018 - $158,255
8,559 New
8,559 $124,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.